{"id":"https://openalex.org/W97502871","doi":null,"title":"Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells.","display_name":"Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells.","alternate_titles":[],"publication_year":2001,"publication_date":"2001-09-01","ids":{"openalex":"https://openalex.org/W97502871","mag":"97502871","pmid":"https://pubmed.ncbi.nlm.nih.gov/11848518"},"language":"en","primary_location":{"id":"pmid:11848518","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11848518","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W97502871"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"N Ahmed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119664326","display_name":"University of Wolverhampton","ror":"https://ror.org/01k2y1055","country_code":"GB","type":"education","lineage":["https://openalex.org/I119664326"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"N Ahmed","raw_affiliation_strings":["Division of Biomedical Sciences, School of Health Sciences, University of Wolverhampton, England, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biomedical Sciences, School of Health Sciences, University of Wolverhampton, England, UK","institution_ids":["https://openalex.org/I119664326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020193928","display_name":"Louise Laverick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Laverick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113755742","display_name":"J. Sammons","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Sammons","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050903512","display_name":"H Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044391304","display_name":"David J. Maslin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D J Maslin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111998844","display_name":"H. T. Hassan","orcid":"https://orcid.org/0000-0003-4750-6538","observed_orcids":["https://orcid.org/0000-0003-4750-6538"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H T Hassan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.7451,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.92414279,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"21","issue":"5","first_page":"3519","last_page":"3523"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11979","display_name":"Garlic and Onion Studies","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1110","display_name":"Plant Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11979","display_name":"Garlic and Onion Studies","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1110","display_name":"Plant Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13124","display_name":"Chemical synthesis and alkaloids","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ajoene","display_name":"ajoene","score":0.9990000128746033},{"id":"https://openalex.org/keywords/garlic-derived-compounds","display_name":"garlic-derived compounds","score":0.9319999814033508},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9380000233650208},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.8870000243186951},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7139999866485596},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.8920000195503235},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.9789999723434448},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":1.0},{"id":"https://openalex.org/keywords/allicin","display_name":"allicin","score":0.7149999737739563},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6539999842643738},{"id":"https://openalex.org/keywords/anticancer-natural-products","display_name":"anticancer natural products","score":0.5770000219345093},{"id":"https://openalex.org/keywords/blastic-crisis","display_name":"blastic crisis","score":0.39899998903274536}],"concepts":[{"id":"https://openalex.org/C2781005338","wikidata":"https://www.wikidata.org/wiki/Q409641","display_name":"Allicin","level":2,"score":0.6698190569877625},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.648414134979248},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6275471448898315},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5700169801712036},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.5048085451126099},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.46970388293266296},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4395948648452759},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.43693381547927856},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4260510802268982},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4127844274044037},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3267989158630371},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.314566045999527},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.2659326195716858},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13582637906074524},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12164297699928284},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.09589523077011108},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.06034579873085022}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004220","descriptor_name":"Disulfides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005737","descriptor_name":"Garlic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010936","descriptor_name":"Plant Extracts","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013454","descriptor_name":"Sulfoxides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014740","descriptor_name":"Vidarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014740","descriptor_name":"Vidarabine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018952","descriptor_name":"Antigens, CD34","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D020169","descriptor_name":"Caspases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053148","descriptor_name":"Caspase 3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11848518","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11848518","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:97502871","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11848518","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2066313395","https://openalex.org/W1924990972","https://openalex.org/W2069341720","https://openalex.org/W2148758723","https://openalex.org/W1974166735","https://openalex.org/W1986726314","https://openalex.org/W2051716048","https://openalex.org/W2125771470","https://openalex.org/W2074742324","https://openalex.org/W2923826523"],"abstract_inverted_index":{"UNLABELLED:":[0],"The":[1,133,276,320],"reputation":[2],"of":[3,18,33,53,70,117,135,144,151,165,181,186,195,203,253,279,294,322,327,348,356],"garlic":[4,22],"as":[5],"an":[6],"effective":[7],"remedy":[8],"for":[9,345,372],"tumours":[10],"extends":[11],"back":[12],"to":[13,64,86,126,140,212,224,366],"the":[14,31,51,115,136,142,149,215,250,254,288,302,310,325,338,346,354],"Egyptian":[15],"Codex":[16],"Ebers":[17],"1550":[19],"BC.":[20],"Several":[21],"compounds,":[23],"including":[24,75],"allicin":[25,48],"and":[26,49,67,79,128,155,168,183,259,284,306,332],"its":[27],"corresponding":[28],"sulfide,":[29],"inhibit":[30,65],"proliferation":[32,66],"several":[34],"human":[35,71,172],"malignant":[36,108],"cells.":[37,176,246,265,318,335],"Ajoene":[38,247],"is":[39,105],"a":[40,54,93,106,121,342,368],"garlic-derived":[41],"compound":[42],"produced":[43],"most":[44],"efficiently":[45],"from":[46,92,217,377],"pure":[47],"has":[50,120],"advantage":[52],"greater":[55],"chemical":[56],"stability":[57],"than":[58,240],"allicin.":[59],"Recently,":[60],"ajoene":[61,83,145,210,323,349,373],"was":[62,84,139],"shown":[63,85],"induce":[68,87],"apoptosis":[69,89],"leukaemia":[72,96,103,174,205,245,317],"CD34-negative":[73],"cells":[74,119,206,286,376],"HL-60,":[76],"U937,":[77],"HEL":[78],"OCIM-I.":[80],"More":[81],"significantly,":[82],"30%":[88],"in":[90,98,110,148,163,170,221,229,242,263,271,281,314,329,353,374,380],"myeloblasts":[91],"chronic":[94],"myeloid":[95,102,173,244,316],"patient":[97],"blastic":[99],"crisis.":[100],"Acute":[101],"(AML)":[104],"heterogeneous":[107],"disease":[109,112],"which":[111],"progression":[113],"at":[114],"level":[116,313],"CD34-positive":[118],"major":[122],"impact":[123],"on":[124,146,238,261],"resistance":[125],"chemotherapy":[127,352],"relapse.":[129],"MATERIALS":[130],"AND":[131],"METHODS:":[132],"aim":[134],"present":[137,339],"study":[138],"investigate":[141],"effect":[143,237,252,371],"changes":[147],"expression":[150],"apoptosis-related":[152],"proteins:":[153],"bcl-2":[154,182,196],"caspase-3,":[156],"induced":[157],"by":[158],"two":[159,255,303],"principal":[160],"drugs":[161],"used":[162],"treatment":[164,202,355],"AML,":[166],"cytarabine":[167,241,258,305],"fludarabine,":[169,260,307],"KGI":[171,264,282,315,334],"CD34-positive-resistant":[175],"Both":[177],"quantitative":[178,289],"ELISA":[179,193,290],"measurement":[180,185,194,293],"colourimetric":[184],"active":[187],"caspase-3":[188,296,312,328],"were":[189],"used.":[190],"RESULTS:":[191],"Quantitative":[192,292],"(units":[197],"per":[198,298],"million":[199,299],"cells)":[200,300],"showed":[201,301],"KG1-resistant":[204],"with":[207,350],"40":[208],"microM":[209],"alone":[211],"significantly":[213,234,248,308],"reduce":[214],"bcl-2-expression":[216,239,262,280],"239.5":[218],"+/-":[219,227],"1.5":[220],"control":[222,283],"cultures":[223],"only":[225],"22.0":[226],"4.0":[228],"ajoene-treated":[230,274],"cultures.":[231,275,382],"Fludarabine":[232],"had":[233],"more":[235],"inhibitory":[236,251],"KGI-resistant":[243],"enhanced":[249,324],"chemotherapeutic":[256],"drugs,":[257,304],"Bcl-2-expression":[266],"could":[267],"not":[268],"be":[269],"detected":[270],"fludarabine":[272],"+":[273],"Western":[277],"blot":[278],"treated":[285],"confirmed":[287],"measurements.":[291],"activated":[295,311],"(pg":[297],"increased":[309],"CONCLUSION:":[319],"addition":[321],"activation":[326],"both":[330],"cytarabine-":[331],"fludarabine-treated":[333],"In":[336],"conclusion,":[337],"results":[340],"suggest":[341],"potential":[343],"role":[344],"combination":[347],"fludarabine-based":[351],"refractory":[357],"and/or":[358],"relapsed":[359],"AML":[360,378],"patients.":[361],"Further":[362],"studies":[363],"are":[364],"warranted":[365],"evaluate":[367],"similar":[369],"enhancing":[370],"blast":[375],"patients":[379],"primary":[381]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W97502871","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
